, Tracking Stock Market Picks
Enter Symbol:
galena biopharma (GALE) [hlAlert]

down 26.96 %

galena biopharma (GALE) rated Buy with price target $5 by MLV & Co

Posted on: Thursday,  Nov 20, 2014  8:25 AM ET by MLV & Co

MLV & Co rated Buy galena biopharma (NASDAQ: GALE) on 11/20/2014. Previously MLV & Co rated Buy galena biopharma (NASDAQ: GALE) on
10/25/2012., when the stock price was $2.04. Since then, galena biopharma has lost 26.96% as of 01/21/2016's recent price of $1.49.
If you would have followed the previous MLV & Co's recommendation on GALE, you would have lost 26.96% of your investment in 1183 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

MLV & Co is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries such as metals and mining, life sciences, energy and real estate. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market(ATM) transaction market.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2014 8:25 AM Buy
1.85 5.00
as of 10/17/2014
1 Week up  8.77 %
1 Month down  -16.21 %
3 Months down  -27.90 %
1 YTD down  -62.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/25/2012 8:25 AM Buy
2.04 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy